US Department of Health and Human Services (HHS) Secretary Alex Azar outlined tools and tactics today that the Trump administration will use to try to rein in rising pharmaceutical costs, including hinting at a potential targeted presidential public outburst and detailing revisions to Medicare and Medicaid purchasing policies.